10-K: Iris Acquisition Corp II Details SPAC Structure in 10-K

Iris Acquisition Corp II, a blank check company, filed its annual report detailing its structure, search for a business combination, and financial position as of December 31, 2025.

Summary

• Iris Acquisition Corp II is a newly organized Special Purpose Acquisition Company (SPAC) incorporated on July 8, 2025, with no operating history or revenues to date.
• The company completed its Initial Public Offering (IPO) on February 4, 2026, raising gross proceeds of $168,500,000 from 16,850,000 units at $10.00 per unit.
• Simultaneously with the IPO, 438,000 private placement units were sold to the sponsor and underwriters, generating an additional $4,380,000.
• A total of $168,500,000 from the IPO and private placement proceeds was placed in a trust account, to be invested in U.S. government treasury obligations or money market funds.
• The company has 24 months from the IPO closing (February 4, 2026) to complete an initial business combination, or it will liquidate and redeem public shares.
• The target business for the combination must have a fair market value of at least 80% of the assets in the trust account (excluding deferred underwriting commissions and taxes payable).
• As of December 31, 2025, the company reported a net loss of $68,023 and a working capital deficit of $182,621, which is typical for a pre-business combination SPAC.
• The management team, based in Dubai, has a stated generalist investment approach but prioritizes sectors like Technology, Media & Telecommunications (TMT), Business & IT Services, Consumer Products & Digital Brands, Hospitality & Real Estate Platforms, Education & EdTech, Logistics & Mobility, Automotive & Industrial Technologies, and FinTech & Crypto.
• The company's units, Class A ordinary shares, and warrants are listed on the NYSE under symbols IRABU, IRAB, and IRABW, respectively.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing with a moderately positive sentiment. While the company is a pre-revenue SPAC with inherent risks and potential conflicts of interest, the experienced management team, clear investment strategy, and substantial trust account balance provide a solid foundation for its stated objective.

Positives

• The management team has extensive experience in investment banking, M&A advisory, private equity, and corporate finance across North America, the Middle East, Asia, and Europe.
• The team successfully sponsored and led a previous SPAC, Iris Acquisition Corp., which completed a business combination with Liminatus Pharma, Inc., demonstrating a proven track record.
• The company has a clear investment framework targeting mid-market companies with meaningful revenue, a path to profitability, established operating history, and strong management.
• The SPAC structure offers target businesses an expedited path to public listing, access to capital markets, and a listed public currency for future growth.
• The trust account holds a substantial $168,500,000, providing significant capital for a business combination.

Negatives

• The company has no operating history or revenues to date, making its future success entirely dependent on the performance of an as-yet-unidentified target business.
• There is inherent uncertainty in identifying and completing a suitable business combination within the 24-month timeframe.
• Management's discretion in selecting a target business and determining its fair market value means investors rely heavily on their judgment.
• Potential conflicts of interest exist due to officers and directors having fiduciary or contractual obligations to other entities and their indirect ownership of founder shares and private placement units.
• Public shareholders may suffer significant dilution if additional financing is raised through equity or convertible debt issuances for a business combination.

Risks

• Geopolitical instability, including the Russia-Ukraine conflict and the US-Israel-Iran conflict, could lead to market disruptions, volatility, and increased cyberattacks, adversely affecting the search for a business combination.
• The company is a blank check company with no operating history and no revenues, making its ability to select an appropriate target business uncertain.
• Failure to complete an initial business combination within 24 months from the IPO closing will result in liquidation and redemption of public shares, with warrants expiring worthless.
• The company's lack of business diversification post-acquisition could subject it to negative economic, competitive, and regulatory developments in a single industry.
• Cybersecurity threats to third-party digital technologies could lead to corruption or misappropriation of assets, proprietary information, and sensitive data, with the company lacking significant investments in data security protection.
• The fair market value of the target business is determined by the Board of Directors, and investors rely on their business judgment, which may involve a substantial degree of judgment.
• Conflicts of interest may arise from management's affiliations with other entities and their personal financial interests in the founder shares and private placement units.
• The inability to obtain additional financing, if required, could prevent the completion of a business combination.
• The requirement for public shareholders to tender share certificates for redemption may pose a logistical challenge and reduce flexibility for shareholders.

Future Outlook

The company intends to identify and combine with a high-quality, small to mid-market company poised for accelerated growth through a public listing within 24 months from the IPO closing. It aims to capitalize on its management team's experience and networks to source target businesses, focusing on those that can benefit from public market access and operational support. The company expects to generate non-operating income from interest on the trust account until a business combination is completed.

Management Comments

• "We are a globally focused SPAC with a generalist investment approach, seeking to identify and combine with a high-quality, small to mid-market company that is poised to unlock accelerated growth through a public listing."
• "We intend to primarily focus our target sourcing efforts on private companies that we believe would benefit from a public listing and partnership with our team and that otherwise cannot gain access to public capital in this current market environment."
• "Our management teams caliber and experience position us to be a value adding partner to the target companys leadership team throughout the deSPAC process and beyond."
• "We believe that our new SPAC is timely and relevant to support enhancement of public capital investments in growing and commercializing innovative small and middle-cap exceptional companies."

Industry Context

StockSavvy.ai notes that Iris Acquisition Corp II operates within the highly competitive SPAC market, seeking to leverage its management's prior successful SPAC experience (Iris Acquisition Corp. with Liminatus Pharma, Inc.) and global network. The company's generalist investment approach, coupled with a focus on technology-driven transformation across various sectors, aligns with broader market trends favoring innovative and scalable businesses. The emphasis on providing an alternative to traditional IPOs for mid-market companies reflects a common value proposition in the SPAC industry.

Management Changes

Corporate Governance

Legal Proceedings

• No material litigation, arbitration, or governmental proceeding is currently pending against the company or any members of its management team.
• The company is not aware of any legal proceeding, investigation, or claim that has a more than remote possibility of having a material adverse effect on its business, financial condition, or results of operations.

Related Party Transactions

• On July 15, 2025, the sponsor purchased 5,750,000 Class B ordinary shares for $25,000, with 133,333 shares later forfeited due to partial over-allotment exercise.
• The sponsor purchased 251,000 private placement units at $10.00 per unit for $2,510,000, and the underwriters purchased 187,000 private placement units for $1,870,000, simultaneously with the IPO.
• The sponsor loaned the company up to $300,000 for IPO expenses, with $75,806 borrowed as of December 31, 2025, and the note fully settled on February 4, 2026.
• The sponsor will charge the company $20,000 per month for office space, administrative, and support services, commencing February 2, 2026, until a business combination or liquidation, for up to six months unless working capital loans permit longer payment.
• Officers, directors, or their affiliates may loan funds for transaction costs, convertible into private placement units, with up to $1,500,000 of such loans possible.

Stakeholder Impact

• Shareholders: Public shareholders face the risk of liquidation if no business combination is completed within 24 months, but are entitled to redemption of their shares from the trust account. They also face potential dilution from future capital raises and warrant exercises. Founder shares and private placement shares held by the sponsor and management are subject to lock-up periods and forfeiture conditions.
• Employees: The company has no full-time employees prior to a business combination. Post-combination, stock-based compensation may be used to motivate and retain employees of the target business.
• Customers/Suppliers: Impact is currently minimal as the company has no operations. Post-combination, the target business's customers and suppliers would be affected by the new public company structure and strategic initiatives.
• Creditors: The trust account is generally protected from third-party claims, but there is no guarantee that all vendors will waive their rights to the trust account, potentially impacting the amount available for public shareholders upon liquidation.

Next Steps

• Identify and evaluate potential target businesses for an initial business combination.
• Conduct extensive due diligence on prospective target businesses.
• Structure, negotiate, and complete a business combination within 24 months from the IPO closing (by February 4, 2028).
• File a registration statement for the Class A ordinary shares issuable upon exercise of warrants within 15 business days after the closing of the initial business combination.

Key Dates

Recommendation

Iris Acquisition Corp II is a blank check company (SPAC) that has recently completed its IPO and is actively searching for a business combination. While the management team has a strong track record with a previous successful SPAC, the company currently has no operations or revenue. Investing in a SPAC at this stage is highly speculative, as its future performance is entirely dependent on the successful identification and acquisition of a suitable target business. The 24-month deadline for a business combination introduces a time-sensitive risk. A 'hold' recommendation is appropriate for existing investors who understand the speculative nature and are awaiting the announcement of a target, while new investors should exercise caution due to the inherent uncertainties of a pre-deal SPAC.

Keywords

SPAC, Special Purpose Acquisition Company, Blank Check Company, Business Combination, IPO, Warrants, Class A Ordinary Shares, Class B Ordinary Shares, Trust Account, SEC Filing, Financial Reporting, Corporate Governance, Investment Strategy, Dubai, Cayman Islands